25th-May-2013 17:04Source: BSE

Plethico Pharma- Board to consider Bonus Issue

Plethico Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 01, 2013, inter alia, to consider issue of Bonus shares to public shareholder...

15th-May-2013 14:13Source: NSE

Plethico Pharmaceuticals Limited

Plethico Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 14, 2013, inter-alia, considered the following :(1) Fixing the June 28,...

15th-May-2013 13:04Source: BSE

Plethico Pharma- Outcome of Board Meeting (AGM on June 28, 2013)

Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter-alia, considered the following :

1. Fixing the June 28, 2013 ...

14th-May-2013 19:39Source: NSE

Plethico Pharmaceuticals Limited

Plethico Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results along with the Limited Review Report for the period ended March 31,2013.

14th-May-2013 19:10Source: BSE

Plethico Pharma- Financial Results & Limited Review for March 31, 2013

Plethico Pharmaceuticals Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended March 31, 2013.

17th-Apr-2013 17:38Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Sashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

6th-Apr-2013 09:47Source: BSE

Plethico Pharma- Outcome of EGM (Clause 35A)

Plethico Pharmaceuticals Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on April 05, 2013, under Clause 35A.

1st-Apr-2013 12:00Source: NSE

Plethico Pharmaceuticals Limited

Shashikant Patel has submitted to the Exchange, vide letter dated March 26, 2013 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulatio...

1st-Apr-2013 11:11Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant A Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

18th-Mar-2013 19:27Source: BSE

Plethico Pharma- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Plethico Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992